552 related articles for article (PubMed ID: 20018889)
1. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.
Wu JW; Breydo L; Isas JM; Lee J; Kuznetsov YG; Langen R; Glabe C
J Biol Chem; 2010 Feb; 285(9):6071-9. PubMed ID: 20018889
[TBL] [Abstract][Full Text] [Related]
2. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
Kayed R; Head E; Sarsoza F; Saing T; Cotman CW; Necula M; Margol L; Wu J; Breydo L; Thompson JL; Rasool S; Gurlo T; Butler P; Glabe CG
Mol Neurodegener; 2007 Sep; 2():18. PubMed ID: 17897471
[TBL] [Abstract][Full Text] [Related]
3. Conformational stability of fibrillar amyloid-beta oligomers via protofilament pair formation - a systematic computational study.
Kahler A; Sticht H; Horn AH
PLoS One; 2013; 8(7):e70521. PubMed ID: 23936224
[TBL] [Abstract][Full Text] [Related]
4. Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity.
Ladiwala AR; Litt J; Kane RS; Aucoin DS; Smith SO; Ranjan S; Davis J; Van Nostrand WE; Tessier PM
J Biol Chem; 2012 Jul; 287(29):24765-73. PubMed ID: 22547072
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils.
Bieschke J; Herbst M; Wiglenda T; Friedrich RP; Boeddrich A; Schiele F; Kleckers D; Lopez del Amo JM; Grüning BA; Wang Q; Schmidt MR; Lurz R; Anwyl R; Schnoegl S; Fändrich M; Frank RF; Reif B; Günther S; Walsh DM; Wanker EE
Nat Chem Biol; 2011 Nov; 8(1):93-101. PubMed ID: 22101602
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic C-terminal beta-sheet interactions determine the formation of fibril or amyloid beta-derived diffusible ligand-like globulomer for the Alzheimer Abeta42 dodecamer.
Ma B; Nussinov R
J Biol Chem; 2010 Nov; 285(47):37102-10. PubMed ID: 20847046
[TBL] [Abstract][Full Text] [Related]
7. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
[TBL] [Abstract][Full Text] [Related]
8. Role of water in protein aggregation and amyloid polymorphism.
Thirumalai D; Reddy G; Straub JE
Acc Chem Res; 2012 Jan; 45(1):83-92. PubMed ID: 21761818
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
[TBL] [Abstract][Full Text] [Related]
10. The Properties of Amyloid-β Fibrils Are Determined by their Path of Formation.
Brännström K; Islam T; Gharibyan AL; Iakovleva I; Nilsson L; Lee CC; Sandblad L; Pamrén A; Olofsson A
J Mol Biol; 2018 Jun; 430(13):1940-1949. PubMed ID: 29751013
[TBL] [Abstract][Full Text] [Related]
11. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
[TBL] [Abstract][Full Text] [Related]
12. The Alzheimer's amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization.
Tay WM; Huang D; Rosenberry TL; Paravastu AK
J Mol Biol; 2013 Jul; 425(14):2494-508. PubMed ID: 23583777
[TBL] [Abstract][Full Text] [Related]
13. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology.
Nichols MR; Moss MA; Reed DK; Cratic-McDaniel S; Hoh JH; Rosenberry TL
J Biol Chem; 2005 Jan; 280(4):2471-80. PubMed ID: 15528204
[TBL] [Abstract][Full Text] [Related]
15. Protofibril-Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation.
Hasecke F; Niyangoda C; Borjas G; Pan J; Matthews G; Muschol M; Hoyer W
Angew Chem Int Ed Engl; 2021 Feb; 60(6):3016-3021. PubMed ID: 33095508
[TBL] [Abstract][Full Text] [Related]
16. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
[TBL] [Abstract][Full Text] [Related]
17. Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.
Nichols MR; Colvin BA; Hood EA; Paranjape GS; Osborn DC; Terrill-Usery SE
Biochemistry; 2015 Apr; 54(13):2193-204. PubMed ID: 25756466
[TBL] [Abstract][Full Text] [Related]
18. Toxic fibrillar oligomers of amyloid-β have cross-β structure.
Stroud JC; Liu C; Teng PK; Eisenberg D
Proc Natl Acad Sci U S A; 2012 May; 109(20):7717-22. PubMed ID: 22547798
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
[TBL] [Abstract][Full Text] [Related]
20. Understanding Amyloid-β Oligomerization at the Molecular Level: The Role of the Fibril Surface.
Barz B; Strodel B
Chemistry; 2016 Jun; 22(26):8768-72. PubMed ID: 27135646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
